UPC_CoA_22/2026

NOVEL ANTITUMORAL USE OF CABAZITAXEL

AppealsMain AppealCourt of AppealAppealWritten Phase

Parties

Sanofi Mature IP, Sanofi Winthrop Industrie, Sanofi-Aventis France, Sanofi-Aventis GmbH, Sanofi Belgium, Sanofi-Aventis Deutschland GmbH, Sanofi S.r.l., Sanofi B.V., Sanofi - Produtos Farmaceuticos Lda, Sanofi AB, Sanofi A/SvSanofi Mature IP, Sanofi Winthrop Industrie, Sanofi-Aventis France, Sanofi-Aventis GmbH, Sanofi Belgium, Sanofi-Aventis Deutschland GmbH, Sanofi S.r.l., Sanofi B.V., Sanofi - Produtos Farmaceuticos Lda, Sanofi AB, Sanofi A/S

Judges

Patents

CPC codes: A61K38/193, A61K31/573, A61P35/04, A61K31/164, A61K31/56, A61P43/00, A61P13/08, A61P15/00, A61K31/337, A61P35/00, A61K45/06, A61P25/16

Sector: Pharmaceutical & Medical

Outcome

—

Filed: Feb 12, 2026

First decided: —

Language: English